Optimal timing for hepatitis C antiviral therapy in the peritransplant period?

Hepatology. 2017 Sep;66(3):1004. doi: 10.1002/hep.29300. Epub 2017 Jul 27.

Authors

George Cholankeril¹, Robert J Wong², Donghee Kim³, Aijaz Ahmed³

Affiliations

¹ Department of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, TN.
² Division of Gastroenterology and Hepatology Alameda Health System, Highland Hospital, Oakland, CA.
³ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA.

PMID: 28586088
DOI: 10.1002/hep.29300

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Hepacivirus*
Hepatitis C*
Hepatitis C, Chronic
Humans

Substances

Antiviral Agents